Physician profile
Mitchell Herold
NPI 1487113452
$4,084.73
in general payments reported to CMS, 2019-2025
18 companies · $1,674 in 2025
The $1,674 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $810 · 2024: $1,600 · 2025: $1,674.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,004 · Education: $80.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,003.87 |
| Education | $80.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $1,190.48 | 2023-2025 | Dupixent, Libtayo |
| Abbvie INC. | $837.18 | 2023-2025 | |
| Genzyme Corporation | $608.38 | 2023-2025 | |
| Incyte Corporation | $221.72 | 2023-2025 | Opzelura |
| Dermavant Sciences, INC. | $208.03 | 2023-2024 | Vtama |
| Ucb, INC. | $172.59 | 2025 | Bimzelx |
| Galderma Laboratories, L.P. | $162.63 | 2025 | Nemluvio |
| Janssen Scientific Affairs, LLC | $133.17 | 2024 | Tremfya |
| Krystal Biotech INC | $124.98 | 2025 | Vyjuvek |
| Lilly USA, LLC | $124.60 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $100.18 | 2023 | Sotyktu |
| Janssen Biotech, INC. | $54.09 | 2024-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $32.41 | 2023 | Odomzo |
| Leo Pharma INC. | $32.39 | 2024-2025 | Adbry |
| Novartis Pharmaceuticals Corporation | $32.17 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $19.01 | 2025 | Vtama |
| Pfizer INC. | $16.19 | 2025 | |
| Paratek Pharmaceuticals, INC. | $14.53 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Herold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.